Clinical Trials · NCT07587775

The Effect of Osteoporotic Medications on Vertebral Bone Quality Score

Enrolling By InvitationPhase 2Abaloparatide (Investigational)
Phase
Phase 2
Recruitment status
Enrolling By Invitation
Sponsor
State University of New York at Buffalo
Enrollment
60
Start date
Jun 2026
Locations
1 site, United States
Primary endpoint
Improvement in Bone Quality
View Abaloparatide compound reference